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ABSTRACT 
Objective: Human immunodeficiency virus (HIV), hepatitis B virus, and hepatitis C viruses (HCV) are 
major causes of mortality and morbidity worldwide. They are also among the commonest transfusion-
transmissible infectious agents. Students of higher institutions are often used as voluntary unpaid 
donors by many hospitals in Nigeria. In this study, the prevalence of HIV and HCV and HBsAg is 
determined  in a population of students attending Ladoke Akintola University of Technology in south 
west Nigeria, to provide background information on the burden of these infections in this population. 
Materials and Methods: Serum samples were obtained from students of the Pre-degree Science 
programme of Ladoke Akintola University of Technology, Ogbomosho and tested for antibodies to HIV, 
HCV and HBsAg using the ELISA procedure. 
Results: The prevalence rates of antibodies to HIV and HCV in the student population were 0% and 
4.8%, respectively and that of HBsAg was 9.5%. 
Conclusion:  The findings of this study which showed that the prevalence of antibodies to HIV and of 
HBsAg in this group of students is somewhat similar to those carried out in similar populations. This 
strongly suggests that the viral burden amongst this population of students is similar and that probably 
similar factors (demographic) are responsible for maintaining this level of viral load. Further studies 
would be needed to elucidate the reasons why this is the case. Also it would be necessary to re-
emphasize the methods of prevention of transmission of these viruses, and to ensure their 
implementation in order to reduce the viral levels and therefore avoid the long term sequalae. 
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INTRODUCTION 
Human immunodeficienciency virus (HIV), 
hepatitis B virus and hepatitis C virus 
(HCV) are major causes of morbidity and 
mortality worldwide.  Today, HIV is a 
leading cause of death in many parts of the 
world, especially in African countries. It is 
estimated that over 40 million people world 
wide are living with the virus with over 75 
% of them living in Africa (1).  HIV/AIDS is 
spreading fast globally and in Nigeria, the 
virus infection is now endemic in rural and 
urban areas (2). UNIAIDS estimates that in 
Nigeria around 3.9% of adults between the  
 
ages 15-49years are living with HIV/AIDS 
(1). 
 
Hepatitis B virus infection is endemic in 
many developing parts of the world. It is 
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estimated that globally, there are over 400 
million chronic carrier of the virus (3, 4). 
Studies by several investigators have shown 
that a large percentage of the Nigerian 
population has been infected by HBV and 
that the virus contributes significantly to the 
aetiology of liver diseases in the country (5, 
6). 
About 3% of the world’s population has 
been infected by HCV and over 170 million 
people are chronic carriers (7). Although 
much is known about the epidemiology of 
HBV in Nigeria, limited investigation has 
been carried out on Hepatitis C virus 
infection. 
Among the features common to HIV, HBV 
and HCV is the transmissibility via blood 
transfusion from the donor to the recipient 
of the donated blood. Apart from these three 
viruses many other infectious agents can be 
transmitted through blood transfusion. 
These include Treponema pallidum, 
Plasmodium sp., human T-lymphotrophic 
virus (HTLV), Babesia, Leishmania,  
Trypanosoma cruzi, variant Creutzfeldt-Jacob 
Disease (vCJD) agent, cytomegalovirus 
(CMV)and Epstein Barr virus (EBV). 
Therefore, the need to render donated blood 
and blood products safe before they are 
transfused into a patient has become a major 
challenge for the blood transfusion services 
worldwide. 
 
To ensure that donated blood is safe for 
transfusion, the World Health Organization 
(WHO) has put in place strict criteria for 
safe donation. These include donation by 
voluntary, unpaid, young, healthy, non-
pregnant, adult, low risk and fully 
counseled donors (8). Unfortunately, this 
category of donors is scarce in Nigeria; 
therefore, most blood donations are 
obtained from replacement and paid donors 
who are at high risk for these infections.   
 
.The future of safe blood donation in Nigeria 
lies in the ability of the blood transfusion 
services to recruit and retain voluntary 
unpaid donors. Enquiries made among 
students of Ladoke Akintola University 
revealed many students are willing to serve 
as voluntary unpaid donors. The aim of this 
study was to determine the prevalence of 
HIV infection, HBsAg and HCV antibody in 
students of LAUTECH at the time of 
enrollment into the University and compare 
the results obtained to those from similar 
studies carried out elsewhere. 
 
MATERIALS AND METHODS 
Study Participants 
The participants in this study were 
freshmen enrolled in the Pre-degree Science 
(PDS) programme of Ladoke Akintola 
University of Technology (LAUTECH), 
Ogbomosho, Oyo State. They were recruited 
into an on-going longitudinal study of HIV 
infection in a cohort of students of the 
institution in 2003. A study proforma was 
used to obtain demographic data such as 
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age, sex, state of origin, occupation and state 
of residence of parents were obtained from 
the participants. Informed consent was 
sought at the point of recruitment and blood 
samples were collected only from the 
students who consented to participate in the 
study. Pre-test HIV counseling was also 




Blood samples were collected by 
venipuncture from all consenting study 
participants at the LAUTECH Health 
Center, Ogbomosho, with sterile 5ml plastic 
syringes and 22 gauge needles. After 
collection, blood samples were transported 
in a cooler containing ice pack to the 
Virology Laboratory, Department of 
Medical Microbiology and Parasitology, 
Faculty of Basic Medical Sciences, 
LAUTECH College of Health Sciences, 
Oshogbo, Osun State. Serum was separated 
by low speed centrifugation at 1,500 
revolutions per minute (r.p.m.) and stored at 




Serum samples were tested for antibody 
against HIV-1, and Hepatitis C virus, and 
for Hepatitis B surface antigen (HBsAg). All 
assays were performed using the ELISA 
procedure. 
Assay for HIV antibody was performed 
using GenScreen ELISA kits, Immunocomb 
and Genie 2 rapid test kits. (details of test 
procedure is as described by the 
manufacturer ) 
Test for HBsAg was carried out using the 
Blinotech Diagnositics kit, following the 
procedure described by the manufacturer  
 
The HBsAg EIA is a solid-phase 
simultaneous sandwich immunoassay, 
which employs monoclonal antibodies and 
polyclonal antibodies specific for HBsAg. 
Microtiter well is coated with monoclonal 
antibodies specific for HBsAg. A serum 
specimen is added to the antibody coated 
Microtiter wells together with enzyme 
conjugated polyclonal antibodies. HBsAg, if 
present, will form an antibody-HBsAg-
antibody-enzyme complex. The plate is then 
washed to remove unbound material. 
Finally, a solution of substrate is added to 
the wells and incubated. A blue color will 
develop in proportion to the amount of 
HBsAg present in the specimen. The 
enzyme-substrate reaction can be stopped 
and the result is visualized by naked eye or 
read by EIA plate for absorbance at the 
wavelength of 450nm. 
Hepatitis C antibody was also assayed using 
the clinotech diagnostics kit, following the 
procedure described by the manufacturer.  
 
Principle of the Test 
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This ELISA uses recombinant proteins 
derived from core region of HCV virus to 
detect the presence of HCV antibodies in 
human sera. Multiple epitopes of HCV 
proteins are bonded to the microtiter wells. 
When antibodies to HCV are present in the 
test sample, they react with recombinant 
proteins and attach to the solid-phase. Non-
reactive antibodies are removed with the 
wash buffer. Human IgGs bound to the 
antigen are reacted with goat-anti-human 
IgG peroxides conjugate and visualized by 
subsequent reactions with a chromogenic 
substrate. Positive sample generates a 
medium to dark blue color. No color or very 
pale blue color indicates a negative reaction. 
The intensity of the reaction is 
photometrically quantitated. 
RESULTS 
A total of two hundred and ninety seven 
students were recruited into the study. The 
mean age for males was 19.54 years and for  
females was 18.59 years with an age range of 
15-26 years.  There were 137 males and 160 
females giving a male to female ratio of     .1: 
1.19. Out of all those screened none tested 
positive for HIV-1 with Genscreen ELISA. 
Twenty eight (9.5%) participants tested 
positive for HBsAg, while fourteen (4.8%) 
tested positive for HCV antibody. Those 
who tested positive for HBsAg were found 
to be older than those who tested negative. 
Statistical analysis found this to be 
statistically significant.(p<0.05). So also with 
HBsAg there was a significant association 
between sex and incidence. Males were 
found to be at higher risk for HbsAg than 
females. (p < 0.05). This was however at 
variance with incidence of HCV where no 
significant association between sex and 
hepatitis C status was found. It was noted 
though, that those found to be positive for 
HCV were younger, however this was not 
statistically significant. 
Table 1: Demographic characteristics of Students test for HBsAg, HCV an HIV antibodies 
GENDER                     HEPATITIS C VIRUS 
STATUS POSITIVE NEGATIVE 
MALE 8 129 
FEMALE 6 154 
 
 Table 2: HBsAg, HCV and HIV antibodies among students of a Tertiary Institution 
GENDER                             HIV 
STATUS POSITIVE NEGATIVE 
MALE NIL NIL 
FEMALE NIL NIL 
 
GENDER                 HEPATITIS B VIRUS 
STATUS POSITIVE NEGATIVE 
MALE 20 117 




Studies carried out by various authors have 
shown that HIV, HBV and HCV infections 
are highly prevalent among Nigerians 
(9,10,11,12). Infection by two of these 
viruses, HIV and HBV was the leading 
cause of discarding donated blood at the 
University of Benin Teaching Hospital (13). 
This is probably the case in many blood 
transfusion centers in the country. The 
financial cost of discarding so many units of 
blood is enormous, thus constituting a major 
burden on the health budget.  
The present study showed that none of the 
students tested in this study had HIV 
infection. The prevalence of HIV infection in 
the Nigerian population in 2003, the time 
these blood specimens were collected was 
4.5%. The absence of HIV infection in this 
group of students may be due to the fact 
that most of the students tested were very 
young and were from the high 
socioeconomic group, and were probably 
well-informed through HIV/AIDS 
awareness campaigns about how to avoid 
being infected by HIV.  
 
The prevalence of HBsAg (9.4%) found in 
this study is similar to findings determined 
among university freshmen in Ife (8%) (14). 
However studies in 1985, 17% of antenatal 
clinic patients were positive for HBsAg (15). 
In studies carried out among paid blood 
donors  the HIV seroprevalence rate was 
slightly higher (2.1%) (16) compared to 0% 
obtained here probably due to the fact that 
this group (paid donors) are a well known 
high risk group. 
 The 4.7% prevalence of HCV antibody in 
the student population is a little higher or 
somewhat similar to  reports in previous 
studies in Nigeria (17). However it has been 
shown that it has been shown that HCV 
antibody prevalence is much higher in older 
adults than in young adults. For example, it 
was shown that HCV antibody prevalence 
was much higher (8%) in clergy men aged 
30-39 years (18).  
Future similar studies would specifically 
include HIV II , Nigeria being a West 
African nation. 
The clinical implications of the findings is 
that a significant number of those found 
positive depending on individual immunity 
and other factors , are likely to go on to 
develop the long term sequalae of harboring 
these viruses including cirrhosis and 
hepatocellular carcinoma. Demographically 
it however implies that there are similar 
social and environmental factors  operating 




In conclusion, this study showed that the 
prevalence of HIV and HCV antibodies and 
HBsAg is generally comparable to results 
obtained from similar studies carried out 
elsewhere. From this it can be concluded 
that among this population of students the 
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viral burden is similar because there are 
probably similar factors operating 
demographically, assisting in the 
maintenance of this viral load.  
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